Serum Institute to produce Russia’s Sputnik V vaccine

RDIF announces partnership, SII to produce 300 million doses, first batch likely in Sept

Serum Institute of India (SII) will be producing atleast 300 million doses of Sputnik V a year, with the first batch of the Russian vaccine against Covid-19 from its facility likely to be rolled out in September. These details emerged with the Russia’s sovereign wealth fund RDIF on Tuesday announcing a collaboration with the vaccine maker to manufacture Sputnik V for the India market as well as to exports to several countries. “We have reached a partnership agreement with Serum Institute of India to manufacture Sputnik V,” Russian Direct Investment Fund CEO Kirill Dmitriev said in a media briefing from Moscow. The process of technology transfer to Serum was underway for the last three months and the firm is expected to release the first batch of the vaccine in September.